Clinical Trials Browser

Phase 3 × perflutren × 30 days × Clear all

NCT06024772 2026-06-05

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Phase 3 Not yet recruiting

Prostatic Neoplasms